Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Teladoc (TDOC) PT Raised to $35 at Cantor Fitzgerald
-
Envision Healthcare (EVHC) PT Raised to $40 at Cantor Fitzgerald
-
Genoptix Enters into New Agreements to Acquire Rosetta Genomics for $9 Million in Cash
-
280 CapMarkets Expands Its Corporate Bond Trading Capabilities and Institutional Sales Team
-
Aimmune Therapeutics Announces Closing of Public Offering of Common Stock
-
Strongbridge Biopharma plc Announces Underwriters’ Partial Exercise of Option to Purchase Additional Shares
-
HMS Holdings (HMSY) PT Raised to $17 at Cantor Fitzgerald;'4Q17 Bounce Back but 2018 Guidance is Light'
-
Lifepoint Holdings (LPNT) PT Lowered to $45 at Cantor Fitzgerald; 'Weak Volumes, Bad Debt Hurt 4Q17'
-
Tivity Health (TVTY) PT Raised to $53 at Cantor Fitzgerald
-
Sabra Healthcare REIT Inc. (SBRA) PT Lowered to $25 at Cantor Fitzgerald
-
Freddie Mac Prices $1.1 Billion Multifamily K-Deal, K-F43
-
MedEquities Realty Trust (MRT) PT Lowered to $13 at Cantor Fitzgerald Citing Recent Surge in Interest Rates
-
HealthStream (HSTM) PT Raised to $25 at Cantor Fitzgerald
-
Verisk Analytics (VRSK) PT Raised to $112 at Cantor Fitzgerald, 'Organic Growth Back to Historical Norms"
-
Aimmune Therapeutics (AIMT) Prices 5.5M Share Common Offering at $32/Sh
-
UDR, Inc. (UDR) PT Lowered to $40 at Cantor Fitzgerald
-
Essex Property Trust (ESS) PT Lowered to $264 at Cantor Fitzgerald
-
bluebird bio (BLUE) PT Raised to $122 at Cantor Fitzgerald
-
Aimmune Therapeutics Announces Pricing of Public Offering of Common Stock
-
Cantor Fitzgerald Starts Aduro Biotech (ADRO) at Overweight, 'Leading Edge of I/O'
-
Spring Bank Pharmaceuticals (SBPH) PT Raised to $32 at Cantor Fitzgerald
-
EPAM Systems (EPAM): Strong Fundamentals And Technicals - Cantor Fitzgerald
-
Cantor Fitzgerald Reiterates Overweight on PolarityTE (COOL)
-
Aimmune Therapeutics (AIMT) Offers $150M in Common Equity
-
Aimmune Therapeutics Announces Proposed Public Offering of Common Stock
-
Alkermes (ALKS) PT Lowered to $50 at Cantor Fitzgerald
-
Spark Therapeutics (ONCE) PT Lowered to $100 at Cantor Fitzgerald; Reit. 'Overweight' Rating
-
National Health Investors (NHI) PT Lowered to $75 at Cantor Fitzgerald Citing Higher Rate Environment, Believes Fundamentals Remain Sound
-
EPAM Systems (EPAM) PT Raised to $130 at Cantor Fitzgerald
-
Taiwan Lipsome Company (TLC) Announces Proposed ADS IPO
-
TLC Files Registration Statement for Proposed Initial Public Offering
-
The Cantor Fitzgerald Relief Fund provides direct financial aid to 5,000 Houston-area families hardest hit by Hurricane Harvey
-
Global Payments (GPN) PT Raised to $126 at Cantor Fitzgerald Following 4Q
-
Globant (GLOB): Wait For Better Risk/Reward, PT To $47 - Cantor Fitzgerald
-
Syntel, Inc. (SYNT) PT Raised to $25 at Cantor Fitzgerald
-
Allscripts (MDRX) PT Raised to $18 at Cantor Fitzgerald
-
Zoetis Inc. (ZTS) PT Raised to $90 at Cantor Fitzgerald on 4Q Beat; 'Positive Marco Outlook & Solid Execution... Cash Flow to be Strong'
-
Pre-Open Movers 02/15: (AMAG) (SEDG) (TEVA) Higher; (CDMO) (THS) (NTAP) Lower (more...)
-
athenahealth (ATHN) PT Raised to $140 at Cantor Fitzgerald, '2018 Guidance Suggests Strong Margin Expansion'
-
After-Hours Stock Movers 02/14: (TRIP) (TEVA) (CSCO) Higher; (CDMO) (NTAP) (SPWR) Lower (more...)
-
Orchid Island Capital Announces February 2018 Monthly Dividend and January 31, 2018 RMBS Portfolio Characteristics
-
Fifth Third hires Pichler as head of credit sales
-
Cantor Fitzgerald Starts PolariltyTE Inc. (COOL) at Overweight
-
Cantor Fitzgerald Starts Arsanis Inc. (ASNS) at Overweight
-
Intercept Pharmaceuticals (ICPT) PT Lowered to $58 at Cantor Fitzgerald
-
GoldMining Issues Letter to Shareholders and Reports on Company Plans for 2018
-
Pacific Bio (PACB) Prices 12.5M Share Common Offering at $2.40/Sh
-
Pacific Biosciences of California, Inc. Announces Pricing of Public Offering of Common Stock
-
Pacific Biosciences of California, Inc. Announces Pricing of Public Offering of Common Stock
-
Mudrick Capital Acquisition Corporation Announces Closing of $200,000,000 Initial Public Offering

